SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ward Knutson who wrote (1882)4/1/2003 10:39:39 AM
From: scaram(o)uche  Read Replies (3) of 2243
 
Ward:

MOGN is a "run" stock, and it's had way too much of a run (congratulations!) for my comfort.......

finance.yahoo.com

finance.yahoo.com

So........

either (1) provide substantial background showing that it's still a T/FIF-like candidate, or (2) suggest it again after one of its "trader retreats"? Your choice. If you provide a compelling valuation argument that tempers risk, we'll put it in.

Yes, I realize that, when a company is this close to market with something that could command big-time bucks (palo), the stock sometimes doesn't look back. But, keep in mind that T/FIF most often buys stocks that are ignored and/or out of favor.

What cushions downside risk apart from Salagen? Blitzer is still Chair, so please be sure to differentiate what is real from BS.

;-)

Thanks!

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext